U.S. Bancorp is an American bank holding company based in Minneapolis, Minnesota, and incorporated in Delaware. The company provides banking, investment, mortgage, trust, and payment services products to individuals, businesses, governmental entities, and other financial institutions.
| Revenue (TTM) | $27.89B |
| Gross Profit (TTM) | $27.89B |
| EBITDA | — |
| Operating Margin | 40.10% |
| Return on Equity | 12.80% |
| Return on Assets | 1.20% |
| Revenue/Share (TTM) | $17.94 |
| Book Value | $38.27 |
| Price-to-Book | 1.56 |
| Price-to-Sales (TTM) | 3.32 |
| EV/Revenue | 5.72 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 10.20% |
| Quarterly Revenue Growth (YoY) | 8.40% |
| Shares Outstanding | $1.56B |
| Float | $1.55B |
| % Insiders | 0.13% |
| % Institutions | 84.56% |
Volatility is currently expanding
U.S. Bancorp NYSE: USB expects to restart share repurchases promptly after pausing them in the previous quarter, as it works to build capital and expand its capital markets business following the acquisition of BTIG, executives said at a conference.
MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bancorp to speak at the BancAnalysts Association of Boston Conference.
ATLANTA--(BUSINESS WIRE)--Healthcare organizations have expanded digital payment options for patients, but the systems behind those transactions are not delivering the same gains in financial performance, according to a new survey released today by Elavon, a wholly owned subsidiary of U.S. Bank (NYSE: USB). Elavon's payment technology and expertise are a key part of U.S. Bank's broader commitment to helping healthcare organizations modernize financial operations and deliver more connected payme.
While investors chase AI momentum plays, five income businesses in insurance, banking, and regulated utilities have quietly raised their dividends and kept earnings well above what they pay out.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A proposed federal drug-discount overhaul could quietly funnel billions in new borrowing demand toward the banks already holding hospital credit lines, and the lenders best positioned to profit may surprise you.
Moving up the dividend yield ladder from a chipmaker near 2% to a package carrier above 6% sounds like a straightforward trade, but each step strips away something you probably assumed you were keeping.
U.S. Bancorp delivered solid third-quarter results, with net interest income up 5.6% and diluted EPS increasing 9.8% year over year. Management expects continued growth, supported by higher fee revenue, capital markets, and the BTIG acquisition. Credit quality remains manageable, but rising credit-loss provisions and broader economic vulnerabilities warrant caution.
U.S. Bancorp gets upgraded to a buy, reflecting strong Q3 earnings, robust credit ratings, and a favorable consensus outlook. USB delivered record Q3 net revenue, with 5.6% YoY net interest income growth, 14.9% fee growth, and 8% YoY average loan growth. ROE and operating margin trends outpace peers, while a diversified loan book and physical branch network support resilience and brand strength.
U.S. Bancorp delivered better-than-expected Q3 earnings, driven by strong fee-based growth and robust commercial loan demand. USB achieved 10% year-over-year earnings growth and more than 5% net interest income growth, underpinned by expanding its commercial loan portfolio. Shares are valued attractively at 1.47x book value, with upside risk skewed due to a favorable rate environment and resilient fundamentals.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on USB and any ticker you trade — then tracks every position and per-strategy win rate.
